Health and Quality of Life Outcomes is an open access, peer-reviewed journal offering rapid publication and wide diffusion in the public domain of high-quality articles in the field of Health-Related Quality of Life (HRQOL).
Health and Quality of Life Outcomes considers original research manuscripts using appropriate quantitative or qualitative methods, systematic reviews/meta-analyses, seminar papers, study protocols, commentaries on articles, and letters to the editor where the main focus is HRQOL. We welcome contributions in the following areas:

Hypothesis-based or theory-driven primary or secondary analyses using observational or experimental data using HRQOL information as an independent or dependent variable;
Systematic reviews and/or meta-analyses of HRQOL studies following appropriate reporting guidelines (e.g., PRISMA);
Articles describing novel theoretical frameworks created to underpin the development or use of HRQOL instruments;
Submissions describing the psychometric properties of instruments measuring HRQOL or similar patient reported outcomes, including the validation of existing instruments in new populations, settings, or contexts;
Methodological and applied research using preference elicitation exercises to report the estimation of value sets to inform health valuation; and  
Study protocols of planned or ongoing research studies, provided data collection is not complete and analyses have not yet begun.

To encourage the submission of high-quality work, all manuscripts submitted to the journal should conform to the relevant reporting guidelines (e.g., PRISMA, PRISMA-P, MOOSE, STROBE, CONSORT). Systematic reviews/meta-analyses and randomized controlled trials will only be considered for publication if they are preceded by a registry listing (e.g., PROSPERO, clinicaltrials.gov) or a published study protocol.

Research article
Commentary
Letter to the Editor
Review
Short report
Study protocol

Editor-in-Chief
Prof Holger Schunemann, McMaster University, Canada
Deputy Editor
Dr Feng Xie, McMaster University, Canada
Associate Editors
Dr Eduardo Bernabé, King's College London, UK
Dr Claudio Bilotta, Presidio Territoriale Poliambulatori, ASST Nord Milano, Milan, Italy
Dr Jan Brozek, McMaster University, Canada
Dr Yaolong Chen, Lanzhou University, China
Dr Pablo Alonso Coello, IIB Sant Pau, Spain
Dr Fabio Efficace, GIMEMA, University of Rome, Italy
Prof Eduardo Fernández, University of Chile, Chile
Dr Sai-fu Fung, City University of Hong Kong, China
Dr Joel Gagnier, University of Michigan, USA
Dr Wei Gao, King's College London, UK
Dr Man Hung, Roseman University of Health Sciences, USA
Dr Tatsunori Ikemoto, Aichi Medical University, Japan
Dr Pascal Jean-Pierre, Florida State University College of Medicine, USA
Prof Ali Montazeri, Iranian Institute for Health Sciences Research, ACECR, Iran
Dr Mark Oremus, University of Waterloo, Canada
Prof Jeffery Sloan, Mayo clinic, USA
Dr Georgios Tsakos, University College London, UK
Prof Abebaw Yohannes, Manchester Metropolitan University, UK
Dr Yuan Zhang, McMaster University, Canada
Statistical Advisor
Dr Francesco Cottone, Italian Group for Adult Hematologic Diseases (GIMEMA), Italy
Editorial Board
Dr Giovanni Apolone, Istituto di Ricerche Farmacologiche Mario Negri, Italy
Dr Xavier Badia, IMS health, Spain
Prof Enzo Ballatori, University of L'Aquila, Italy
Prof Clare Bradley, Royal Holloway University of London, UK
Dr David Brennan, The University of Adelaide, Australia
Dr Anne Brédart, Institut Curie, France
Dr Cinzia Brunelli, Fondazione IRCCS INT-MILANO, Italy
Dr Augusto Caraceni, National Cancer Institute, Italy
Dr Mauro Carone, Fondazione Salvatore Maugeri, Italy
Prof Charles S Carver, University of Miami, USA
Dr Paolo G Casali, National Institute of Cancer, Italy
Dr Barrie Cassileth, Memorial Sloan-Kettering Cancer Center, USA
Dr David Cella, Evanston Northwestern Healthcare, USA
Dr Massimo Costantini, National Cancer Institute, Italy
Dr Frank de Charro, Eramus University Rotterdam, Netherlands
Dr Franco De Conno, National Cancer Institute, Italy
Dr Sonya Emerenco, Evanston Northwestern Healthcare, USA
Dr Calliope CF Farsides, Centre of Medical Law and Ethics, UK
Prof James Fitzgerald, University of Michigan, USA
Ms Daniela Goursand, UFMG, Brazil
Prof Luigi Grassi, University of Ferrara, Italy
Dr Thomas Greenfield, Public Health Institute, USA
Dr Digant Gupta, Cancer Treatment Centers of America, USA
Prof Irene J Higginson, King's College London, UK
Dr William Holmes, University of Pennsylvania School of Medicine, USA
Prof Michael Hyland, University of Plymouth, UK
Dr Paul B Jacobsen, Moffitt Cancer Center, USA
Prof Robert M Kaplan, University of California, USA
Dr Anne Kouvonen, Queen's University Belfast, UK
Dr Mark S Litwin, University of California Los Angeles, USA
Dr Ruth McCorkle, Yale University, USA
Prof Susan C McMillan, Health University of South Florida, USA
Prof Linda Moody, University of South Florida, USA
Dr Paola Mosconi, Istituto di Ricerche Farmacologiche Mario Negri, Italy
Dr Brian Ott, Brown Medical School, USA
Dr Eugenio Paci, Center for the Study and Prevention of Cancer, Italy
Dr Franca Porciani, Rizzoli Corriere della Sera - Milano, Italy
Dr Giuseppe Recchia, GSK, Italy
Dr Daniel Reissmann, University Medical Center Hamburg-Eppendorf, Germany
Dr Fausto Roila, Medical Oncology, S. Maria Hospital, Terni, Italy
Dr Amedeo Santosuosso, Ministry of Justice, Italy
Prof Surya Shah, University of Tennessee, USA
Dr John Spertus, University of Missouri, USA
Dr Michele Tomamichel, Psychiatric and Medical Psychology Service, Switzerland
Dr Franco Toscani, Istituto di Ricerca in Medicina Palliativa, Italy
Prof James Varni, Children's Hospital and Health Center, USA
Prof Stephen J Walters, University of Sheffield, UK
Dr Michael Weitzner, Moffitt Cancer Center, USA
Prof Jerome Yesavage, Stanford University, USA